Metabolomic analysis of exosome of pancreatic cancer
Ontology highlight
ABSTRACT:
INSTRUMENT(S): TripleTOF 4600 (AB SCIEX instrument model)
ORGANISM(S): Human
SUBMITTER: 
Juntuo Zhou
PROVIDER: MSV000083669 | MassIVE | Sat Apr 06 22:15:00 BST 2019
REPOSITORIES: MassIVE
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| MSV000083669 | Other | |||
| params.xml | Xml | |||
| statistics.tsv | Tabular | |||
| Sample information.xls | Xls | |||
| 119_Neg.wiff | Wiff |
Items per page: 5 1 - 5 of 392 |
Similar Datasets
Project description:Metabolomics analysis of serum exosomes isolated from pancreatic cancer patients and healthy controls.
2019-04-06 | MSV000083669 | GNPS
Project description:Pancreatic cancer has a dismal prognosis partly due to late diagnosis, where a reliable non-invasive diagnosis is urgently wanted. We here explored, whether serum-derived PaCa exosomes may provide a diagnostic means and microRNA may be advantageous. Exosomes were collected from the serum of 133 patients with pancreatic cancer, 22 patients with non-malignant pancreatic tumors, 25 patients with chronic pancreatitis and 20 healthy donors. Exosomes were isolated by ultracentrifugation and used qRT-PCR for miRNA quantification and miRCURY LNA microRNA Array for miRNA analysis.
2014-12-01 | GSE50632 | GEO
Project description:This study aimed to investigate the proteomic landscape of plasma exosomes from patients diagnosed with PDAC and IPMN, compared to healthy controls (CT), in order to identify potential biomarkers with prognostic and diagnostic values. Additionally, the study aimed to understand the functional role of the exosome's proteome in pancreatic neoplasia. We isolated the plasma exosomes and analyzed its proteome by nano electrospray tandem mass spectrometry (nanoLC-MS/MS), and performed downstream statistical and bioinformatics analysis, using the Perseus (v. 6.2.2), MSigDB (v. 2023.1), STRING (v. 11.5), and NCG (v. 7.1) databases. A total of 319 differentially expressed proteins (DEPs) were identified among the exosome samples, but our analyses focused on the 135 proteins that were expressed in at least 70% of each group's samples to ensure their representative proteomes. Comparing PDAC and IPMN exosome proteomes to controls, we identified 24 and 33 differentially expressed proteins, respectively. Some of the most upregulated proteins in PDAC exosomes were CPN1, IGHV2-26, ITIH3, and CLU, while some of the most downregulated were C4BPB, APOB, CFH, and C1QB. In IPMN exosomes, KLKB1, LBP, CFB, and SERPINA1 were the most upregulated proteins while C5, APOD, C3, and C1QA were downregulated. In general, the protein-protein networks and enrichment analyses revealed interesting interaction clusters and pathways related to cancer development, such as the immune system, complement cascade, clotting-related and vesicle-mediated processes, regulation of insulin-like growth factor transport, platelet activation signaling, and G-protein signaling. Our analyses also highlighted candidate cancer drivers, including the upregulated IGLL, LBP, SERPINA1, SERPINA4, SERPING1, and the downregulated APOB, and C3, which were identified in these pathways and may have potential roles in pancreatic tumorigenesis.
2023-09-04 | PXD042543 | Pride
Project description:Human plasma proteome profiling of pancreatic cancer patients and non-disease healthy controls. EVs isolated (Nova), characterized, and DIA-based proteomics performed. Comparative analyses on oncofactors in EVs, Pancreatic Cancer Markers and various other signaling factors as cargo in cancer EVs
2024-02-21 | MSV000094140 | MassIVE
Project description:To screen differentially expressed tsRNA in serum exosomes of rheumatoid arthritis (RA) patients and healthy controls and conduct bioinformatics analysis for exploring the role and potential clinical application value of tsRNAs in the pathogenesis of RA.
2025-04-08 | GSE293754 | GEO
Project description:827 human miRNA standard human panel Plasma derived extracellular vesicles (EV)/exosomes can serve as markers of cell damage/disease but can also have therapeutic utility depending on the nature of their cargo, such as miRNA. Currently there are challenges and lack of innovations regarding early diagnosis and therapeutic options within different aspects of management of patients suffering from chronic pancreatitis (CP). Use of exosomes as biomarkers for pancreatic health, and/or or as adjuvant therapy would make a difference in management of these patients. To explore the feasibility of this approach, we characterized the miRNA cargo of exosomes purified from CP patients, and compared it to those from healthy participants. Methods: EVs were isolated from plasma of 15 CP patients and 10 healthy controls. Nanoparticle Tracking Analysis was used to determine frequency and size while NanoString technology was used to characterize the miRNA cargo. Relevant clinical parameters were correlated with these EV/exosome characteristics. Results: ~30 miRNA species were identified to have significantly (p<0.05) different expression in exosomes from individuals with CP compared to healthy individuals; ~40 miRNA were differentially expressed in exosomes from pre-diabetic versus non-diabetic CP patients. miR-579-3p, while exhibiting significantly lower (~16-fold) expression in exosomes from CP compared to healthy individuals and lower (~24-fold) in CP narcotic users compared to the less severe CP in non-users, is actually enriched (~32-fold) within exosomes in pre-diabetic CP patients compared to non-diabetic CP patients. A unique pattern was identified in female CP patients. Conclusions: These first of a kind data support the prospect of using a bioinformatics approach to assess pancreatic health, and their therapeutic potential in CP patients.
2021-04-29 | GSE173514 | GEO
Project description:This is a pilot study. We are trying to detect potential salivary biomarkers in mice with a pancreatic tumor. Global gene expression profiling has shown great promise in high-throughput biomarker discovery for early disease detection in body fluids such as saliva, which is accessible, cost-effective, and non-invasive. However, this goal has not been fully realized because saliva, like many clinical samples, contains partially fragmented and degraded RNAs that are difficult to amplify and detect with prevailing technologies. Here, using nanogram scale salivary RNA as a proof-of-principle example, we describe our progress with a novel poly-A tail independent mRNA amplification strategy combined with the Affymetrix GeneChip Exon arrays. We defined a Salivary Exon Core Transcriptome (SECT) with highly similar expression profiles in healthy individuals verified by quantitative PCR. Informatics analysis of SECT provided important mechanistic insight to their potential origin and function. Finally we demonstrated the diagnostic potential of true exon level expression profiling approach with salivary exon biomarkers that accurately discriminated gender in healthy individuals. Recent studies have demonstrated that discriminatory salivary biomarkers can be readily detected upon the development of systemic diseases such as pancreatic cancer, breast cancer, lung cancer and ovarian cancer. However, the utility of salivary biomarkers for the detection of systemic diseases has been undermined due to the absence of biological and mechanistic rationale why distal diseases from the oral cavity would lead to the development of discriminatory biomarkers in saliva. Here, we examine the hypothesis that pancreatic tumor-derived exosomes are mechanistically involved in the development of pancreatic cancer-discriminatory salivary transcriptomic biomarkers. We first developed a pancreatic cancer mouse model that yielded discriminatory salivary biomarkers by implanting the mouse pancreatic cancer cell line Pan02 into the pancreas of the syngeneic host C57BL/6. The role of pancreatic cancer-derived exosomes in the development of discriminatory salivary biomarkers was then tested by engineered a Pan02 cell line that is suppressed for exosome biogenesis, implanted into the C56BL/6 mouse and examine if the discriminatory salivary biomarker profile was ablated or disrupted. Suppression of exosome biogenesis results in the ablation of discriminatory salivary biomarker development. This study supports that tumor-derived exosomes provide a mechanism in the development of discriminatory biomarkers in saliva and distal systemic diseases. We analyzed saliva from 6 healthy mice and 6 mice with a pancreatic tumor using the Affymetrix Mouse Exon Genome 430 2.0 platform. Array data was processed by dChip. No techinical replicates were performed.
2013-06-12 | E-GEOD-47811 | biostudies-arrayexpress
Project description:To explore expression levels of tsRNAs in serumal exosomes, 4 serum specimens were chosen from patients with metastatic breast cancer and 4 samples from healthy subjects. The exosomes were isolated and sent for tsRNA-sequencing.
2023-12-22 | GSE250524 | GEO
Project description:Detailed understanding of host pathogen interaction in tuberculosis is an important avenue for identifying novel therapeutic targets. Extracellular vesicles like exosomes that are rich in protein, nucleic acids and lipids, act as messenger and may show altered composition in infection. In this case control study, we isolated exosomes from serum of 52 subjects (all male, 33 (17-70) in years) including drug naïve active tuberculosis (ATB: n=20), non-tuberculosis (NTB: n=16) and healthy subjects (n=16). Serum exosomal proteome analysis was carried out using isobaric tag for relative and absolute quantification (iTRAQ) experiments and an independent test sample sets (n=36) was used for validation. A set of 132 and 68 proteins were identified in iTRAQ-I (ATB/Healthy) and iTRAQ-II (ATB/NTB) experiments respectively. Analysis of data identified a set of 4 important proteins (KYAT3, SERPINA1, HP and APOC3) that could differentiate ATB subjects from healthy controls successfully and Western data corroborated iTRAQ findings. Identification of such a protein panel in circulating exosomes besides providing novel insights into their role in tuberculosis may prove to be useful targets to develop novel host-directed therapeutic intervention.
2017-12-19 | MSV000081833 | MassIVE
Project description:microRNA profiles of Exosomes from Pooled NPC Patients serum comparing Control Exosomes from Healthy donors serum Two-condition experiment, Exosomes from Pooled Healthy donors serum vs. Exosomes from Pooled NPC Patients serum. Biological replicates: 1 Exosomes from Pooled Healthy donors serum, 1 Exosomes from Pooled NPC Patients serum,
2014-05-06 | E-GEOD-57319 | biostudies-arrayexpress